Clinical trial
Clinical Efficacy and Safety of Antazoline in Comparison to Propafenone in Conversion of Paroxysmal Atrial Fibrillation to Sinus Rhythm - a Single Center, Randomized, Double-blinded Study (the AnProAF Study).
NCT05720572 is registered in ClinicalTrials.gov with Centre of Postgraduate Medical Education as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Efficacy and Safety of Antazoline in Comparison to Propafenone in Conversion of Paroxysmal Atrial Fibrillation to Sinus Rhythm - a Single Center, Randomized, Double-blinded Study (the AnProAF Study).
- Lead sponsor
- Centre of Postgraduate Medical Education
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- September 1, 2019
- Completion date
- January 1, 2026
- Enrollment
- 105 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.